Savvy Advisors Inc. significantly increased its stake in Merck & Co., Inc. (NYSE:MRK) by 109.5% during the third quarter, bringing their total holdings to 16,940 shares valued at $1,422,000. Several other institutional investors also adjusted their positions in the pharmaceutical giant. Analysts have issued new price targets, with a consensus “Hold” rating and an average target price of $120.93.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc.
Savvy Advisors Inc. significantly increased its stake in Merck & Co., Inc. (NYSE:MRK) by 109.5% during the third quarter, bringing their total holdings to 16,940 shares valued at $1,422,000. Several other institutional investors also adjusted their positions in the pharmaceutical giant. Analysts have issued new price targets, with a consensus “Hold” rating and an average target price of $120.93.